Pangaea Oncology (Spain) Price Prediction
| PANG Stock | EUR 1.67 0.02 1.18% |
Momentum 26
Sell Stretched
Oversold | Overbought |
Using Pangaea Oncology hype-based prediction, you can estimate the value of Pangaea Oncology SA from the perspective of Pangaea Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pangaea Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Pangaea because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pangaea Oncology after-hype prediction price | EUR 1.67 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pangaea |
Pangaea Oncology After-Hype Price Prediction Density Analysis
As far as predicting the price of Pangaea Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pangaea Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pangaea Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pangaea Oncology Estimiated After-Hype Price Volatility
In the context of predicting Pangaea Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pangaea Oncology's historical news coverage. Pangaea Oncology's after-hype downside and upside margins for the prediction period are 0.32 and 3.02, respectively. We have considered Pangaea Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pangaea Oncology is moderately volatile at this time. Analysis and calculation of next after-hype price of Pangaea Oncology is based on 3 months time horizon.
Pangaea Oncology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pangaea Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pangaea Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pangaea Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 1.35 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.67 | 1.67 | 0.00 |
|
Pangaea Oncology Hype Timeline
Pangaea Oncology is at this time traded for 1.67on Madrid Exchange of Spain. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Pangaea is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.02%. %. The volatility of related hype on Pangaea Oncology is about 0.0%, with the expected price after the next announcement by competition of 1.67. About 72.0% of the company outstanding shares are owned by corporate insiders. The book value of Pangaea Oncology was at this time reported as 0.46. The company recorded a loss per share of 0.24. Pangaea Oncology had not issued any dividends in recent years. Assuming the 90 days trading horizon the next forecasted press release will be within a week. Check out Pangaea Oncology Basic Forecasting Models to cross-verify your projections.Pangaea Oncology Related Hype Analysis
Having access to credible news sources related to Pangaea Oncology's direct competition is more important than ever and may enhance your ability to predict Pangaea Oncology's future price movements. Getting to know how Pangaea Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pangaea Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| YHSP | Hispanotels Inversiones SOCIMI | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| YEIS | Elaia Investment Spain | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 4.20 | |
| YAZR | Azaria Rental SOCIMI | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| YHCR | Home Capital Rentals | 0.00 | 0 per month | 0.00 | (0.31) | 0.00 | 0.00 | 5.26 | |
| KOM | Plasticos Compuestos SA | 0.00 | 0 per month | 0.00 | (0.19) | 0.00 | (3.00) | 9.31 | |
| MIO | Media Investment Optimization | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TQT | Technomeca Aerospace SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BST | Biotechnology Assets SA | 0.00 | 0 per month | 0.00 | (0.32) | 5.26 | (5.26) | 15.34 |
Pangaea Oncology Additional Predictive Modules
Most predictive techniques to examine Pangaea price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pangaea using various technical indicators. When you analyze Pangaea charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pangaea Oncology Predictive Indicators
The successful prediction of Pangaea Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pangaea Oncology SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pangaea Oncology based on analysis of Pangaea Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pangaea Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pangaea Oncology's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Pangaea Stock analysis
When running Pangaea Oncology's price analysis, check to measure Pangaea Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pangaea Oncology is operating at the current time. Most of Pangaea Oncology's value examination focuses on studying past and present price action to predict the probability of Pangaea Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pangaea Oncology's price. Additionally, you may evaluate how the addition of Pangaea Oncology to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |